Helix Biostructures
Private Company
Funding information not available
Overview
Helix Biostructures is a private, revenue-generating contract research organization (CRO) specializing in structural biology services for the biotech and pharmaceutical industries. Its core business model is providing integrated services across protein production, biophysical characterization, cryo-EM, protein crystallography, and X-ray data collection, with a unique emphasis on a collaborative 'co-sourcing' partnership. The company serves diverse sectors including drug discovery, agricultural biotech, and gene therapy, leveraging its expertise to accelerate client R&D programs. Helix's value proposition centers on flexibility, high-quality data, and deep scientific engagement with clients.
Technology Platform
Integrated structural biology services platform encompassing gene-to-structure workflow: protein production, biophysical characterization, cryo-EM, protein crystallography, and X-ray data collection, delivered via a collaborative 'co-sourcing' partnership model.
Opportunities
Risk Factors
Competitive Landscape
Competes with large, full-service CROs (e.g., Charles River Labs), specialized structural biology boutiques, and academic core facilities. Differentiation is based on the 'co-sourcing' partnership model, integrated service offering, and deep expertise in both cryo-EM and crystallography. Competitors may compete on price, scale, or proprietary technology platforms.